Commencement of BNC210 Phase 2 Clinical Trial for the Treatment of Agitation
Treatment of agitation in the …
Pivotal bioVenture Partners China Closes Inaugural $150 Million Early Stage VC Fund
SHANGHAI, May 24, 2018 /PRNews…
ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA
LUGANO, Switzerland, May 24, 2…
AGC Biologics Cleared for Commercial Manufacture of Portola’s FDA-Approved Andexxa®
-Drug Substance produced in AG…
Samsung BioLogics Receives an additional FDA Approval for its world largest Plant’s Production
– 3rd approval for Plant…
WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan
WCG expands global clinical re…
Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound
MILAN, May 22, 2018 /PRNewswir…
